Scopus:
Exploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies

dc.contributor.authorKocaturk I.
dc.contributor.authorGulten S.
dc.contributor.authorEce B.
dc.contributor.authorKukul Guven F.M.
dc.date.accessioned2024-04-15T07:19:06Z
dc.date.available2024-04-15T07:19:06Z
dc.date.issued2024-03-01
dc.identifier10.3390/diagnostics14060635
dc.identifier.doi10.3390/diagnostics14060635
dc.identifier.scopus2-s2.0-85188906507
dc.identifier.urihttps://hdl.handle.net/20.500.12597/33084
dc.relation.ispartofDiagnostics
dc.relation.ispartofseriesDiagnostics
dc.rightstrue
dc.subjectC-reactive protein | fibrinogen | inflammation | lipoxin A4 | migraine | prostaglandin E2
dc.titleExploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies
dc.typeJournal
dspace.entity.typeScopus
oaire.citation.issue6
oaire.citation.volume14
person.affiliation.nameKastamonu University
person.affiliation.nameKastamonu University
person.affiliation.nameKastamonu University
person.affiliation.nameKastamonu University
person.identifier.orcid0000-0002-3415-6906
person.identifier.orcid0000-0001-5134-1620
person.identifier.orcid0000-0001-6288-8410
person.identifier.orcid0000-0003-3755-6021
person.identifier.scopus-author-id36084791600
person.identifier.scopus-author-id55331044900
person.identifier.scopus-author-id57190287798
person.identifier.scopus-author-id25622351200

Files